Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Inhibitor of growth family, member 1 pseudogene (ENSG00000223672) is a DNA sequence in the human genome that closely resembles the protein-coding ING1 gene but contains mutations that prevent it from producing a functional protein. Such pseudogenes are generally considered nonfunctional in terms of protein expression, though they may sometimes be transcribed into non-coding RNAs that can regulate the expression of related protein-coding genes through RNA interference pathways or by acting as decoys for regulatory microRNAs. However, there is no evidence that this pseudogene itself is a drug target, receptor, enzyme, or other canonical therapeutic target class[1][2][3][6]. This entry is mainly included in gene databases for annotation and evolutionary purposes and should not be considered a therapeutic target in the conventional sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibitor of growth family, member 1 pseudogene.